P3.02b-087 Dose Escalation Study of CDDP plus PEM with Erlotinib and Bev Followed by PEM with Erlotinib and Bev for Non-SQ NSCLC Harboring EGFR Mutations
Tamiya, Motohiro, Tamiya, Akihiro, Shiroyama, Takayuki, Takeoka, Sawa, Naito, Yujiro, Omachi, Naoki, Kimura, Yohei, Morishita, Naoko, Suzuki, Hidekazu, Okamoto, Norio, Okishio, Kyoichi, Kawaguchi, TomVolume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2016.11.1754
Date:
January, 2017
File:
PDF, 125 KB
english, 2017